The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines

Area of Science:

• Cardiology
• Pharmacology

Background:

• Atherosclerotic vascular disease management relies heavily on antiplatelet agents.
• A significant gap exists in comprehensive guidelines for antiplatelet drug use in patients with existing or high-risk cardiovascular disease.

Purpose of the Study:

• To develop evidence-based guidelines for antiplatelet therapy in the outpatient setting.
• To address the underutilization of antiplatelet therapy due to a lack of clear guidance.

Main Methods:

• Review of existing disease-based guidelines.
• Analysis of subsequently published literature.
• Incorporation of expert opinion and review by the Canadian Antiplatelet Therapy Guidelines Committee.

Main Results:

• Specific guidelines are provided for secondary prevention in various patient groups, including post-acute coronary syndromes, post-percutaneous coronary intervention, post-coronary artery bypass grafting, stroke/transient ischemic events, and peripheral arterial disease.
• Guidelines also cover primary prevention and special clinical contexts like diabetes, heart failure, chronic kidney disease, pregnancy/lactation, and perioperative management.
• Recommendations address pharmacologic interactions (e.g., warfarin, clopidogrel, proton-pump inhibitors, aspirin, NSAIDs) and bleeding complication management.

Conclusions:

• The guidelines aim to standardize and improve the use of antiplatelet therapy for cardiovascular disease prevention.
• Clear, evidence-based guidance is expected to address the underuse of these critical medications.
• The guidelines provide a comprehensive resource for clinicians managing patients with or at risk of atherosclerotic vascular disease.